SELARL PHARMACIE SABATIER ET VIDALI : revenue, balance sheet and financial ratios

SELARL PHARMACIE SABATIER ET VIDALI is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARIGNANE (13700), this company of category PME shows in 2022 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - SELARL PHARMACIE SABATIER ET VIDALI (SIREN 501578108)
Kennzahl 2024 2023 2022 2021 2020 2019 2018 2016
Umsatz N/C N/C 1 283 537 € 1 315 391 € 1 283 016 € 1 341 737 € 1 273 201 € 1 216 483 €
Nettoergebnis 11 559 € 535 € 84 457 € 96 086 € 49 673 € 58 010 € 105 259 € 106 525 €
EBITDA N/C N/C 118 718 € 146 772 € 91 631 € 107 008 € 151 510 € 131 187 €
Nettomarge N/C N/C 6.6% 7.3% 3.9% 4.3% 8.3% 8.8%

Umsatz und Gewinn- und Verlustrechnung

In 2024, SELARL PHARMACIE SABATIER ET VIDALI generates positive net income of 12 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 107 k€ -> 12 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

11 559 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 176%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 32%. The balance between equity and debt is satisfactory.

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

176.43%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

32.414%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

3.6%

Entwicklung der Solvenzkennzahlen
SELARL PHARMACIE SABATIER ET VIDALI

Positionnement sectoriel

Debt ratio
176.43 2024
2022
2023
2024
Q1: 16.46
Méd: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELARL PHARMACIE SABATIER... (176.43) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
32.41% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Average

In 2024, the financial autonomy of SELARL PHARMACIE SABATIER... (32.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
12.29 years 2022
2022
Q1: 1.29 years
Méd: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of SELARL PHARMACIE SABATIER... (12.29) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 145.01. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

145.006

Entwicklung der Liquiditätskennzahlen
SELARL PHARMACIE SABATIER ET VIDALI

Positionnement sectoriel

Liquidity ratio
145.01 2024
2022
2023
2024
Q1: 129.47
Méd: 182.13
Q3: 260.78
Average -22 pts über 3 Jahre

In 2024, the liquidity ratio of SELARL PHARMACIE SABATIER... (145.01) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
19.21x 2022
2022
Q1: 0.74x
Méd: 2.5x
Q3: 5.15x
Excellent

In 2022, the interest coverage of SELARL PHARMACIE SABATIER... (19.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
SELARL PHARMACIE SABATIER ET VIDALI

Positionnement de SELARL PHARMACIE SABATIER ET VIDALI dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE SABATIER ET VIDALI is estimated at 161 372 € (range 112 377€ - 241 422€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
112k€ 161k€ 241k€
161 372 € Range: 112 377€ - 241 422€
NAF 5 année 2024

Valuation method used

Net Income Multiple
11 559 € × 14.0x = 161 372 €
Range: 112 377€ - 241 422€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE SABATIER ET VIDALI with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE SABATIER ET VIDALI

What is the revenue of SELARL PHARMACIE SABATIER ET VIDALI ?

The revenue of SELARL PHARMACIE SABATIER ET VIDALI in 2022 is 1.3 M€.

Is SELARL PHARMACIE SABATIER ET VIDALI profitable?

Yes, SELARL PHARMACIE SABATIER ET VIDALI generated a net profit of 12 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE SABATIER ET VIDALI ?

The headquarters of SELARL PHARMACIE SABATIER ET VIDALI is located in MARIGNANE (13700), in the department Bouches-du-Rhone.

Where to find the tax return of SELARL PHARMACIE SABATIER ET VIDALI ?

The tax return of SELARL PHARMACIE SABATIER ET VIDALI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE SABATIER ET VIDALI operate?

SELARL PHARMACIE SABATIER ET VIDALI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.